HHS Colony Stimulating Factors IDIQ

IDIQ

Description

Provide the the Department of Health and Human Services (HHS) with Colony Stimulating Factors to help HHS maintain a permanent supply of medical countermeasures - or the forward deployment of those countermeasures - for use in national medical emergencies. Colony Stimulating Factors are used mitigate injuries caused by exposure to chemical threat agents, biological threat agents, and physical radiologic and nuclear exposures.

Overview

Ceiling

$1,423,850,801

Primary Sponsoring Agency

HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]

Who Can Use

One Agency

Primary NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Primary PSC

AN13 - Health R&D Services; Health Care Services; Experimental Development

Primary Set Aside

None

Extent Competed

Full And Open Competition

HHS Colony Stimulating Factors IDIQ awarded by HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) in September 2013 accepts orders through September 2018. The IDIQ has a reported ceiling of $1,423,850,801, and as of today, $401,645,981 has been obligated through the vehicle with a total reported backlog of $52,433. The IDIQ was awarded full & open and has a primary NAICS code of 325414.

Award Hierarchy

Vehicle

HHS Colony Stimulating Factors IDIQ

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

9/19/13

Start Date

9/28/18

Ordering Period End Date

100% Complete

Task Order Obligations and Backlog

$401.6M

Total Obligated

$401.6M

Current Award

$401.7M

Potential Award

100% Funded

$0.0

Funded Backlog

$52.4K

Total Backlog

Vehicle Award Share

Contractors with greatest percentage of obligations for HHS Colony Stimulating Factors IDIQ

Vehicle Award Share

Federal Award Analysis